trending Market Intelligence /marketintelligence/en/news-insights/trending/CtyKvizmLfV_5nWMmVCfXA2 content esgSubNav
In This List

BioLineRx chief scientific officer to step down

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


BioLineRx chief scientific officer to step down

BioLineRx Ltd.'s chief scientific officer, Merril Gersten, will step down March 31.

The company is yet to announce a replacement for Gersten.